Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sabra Health Care REITSBRA +0.69%84 EV-to-EBIT is 42.50 as of Aug. 07, 2026, which is 69% above its 10-year median of 25.12. GuruFocus rates SBRA with a GF Score™ of 84/100 and a GF Value™ of $20.33 (Fairly Valued). The stock has 12 warning signs investors should review. Among 653 REITs companies, Sabra Health Care REIT ranks worse than 87.44% on this metric.
Sabra Health Care REIT (NAS:SBRA) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Sabra Health Care REIT's Enterprise Value for the quarter that ended in Jun. 2026 was $7,399.4 Mil.
Sabra Health Care REIT's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $183.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sabra Health Care REIT EV-to-EBIT vs REITs Industry
For the REITs industry and Real Estate sector, Sabra Health Care REIT's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Sabra Health Care REIT's EV-to-EBIT falls into.
Sabra Health Care REIT's current Enterprise Value is $7,794.1 Mil.
Sabra Health Care REIT's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $183.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sabra Health Care REIT (SBRA) has a EV-to-EBIT of 42.50 as of Aug. 07, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Sabra Health Care REIT and its competitors. This is 69% above median its historical median of 25.12. According to the industry distribution chart, Sabra Health Care REIT ranks #571 out of 653 companies in the REITs industry, placing it in the top 87.4%.
Is Sabra Health Care REIT's EV-to-EBIT too high?
Sabra Health Care REIT's current EV-to-EBIT of 42.50 is 69% above median its 10-year median of 25.12. The REITs industry median EV-to-EBIT is 18.06. Sabra Health Care REIT's value of 42.50 is 135.3% above this industry median. Based on the distribution chart, Sabra Health Care REIT ranks #571 out of 653 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Sabra Health Care REIT has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sabra Health Care REIT's EV-to-EBIT compare to NHI and HR?
According to the REITs industry distribution chart, Sabra Health Care REIT ranks #571 out of 653 companies for EV-to-EBIT. This places Sabra Health Care REIT in the lower half of its industry. The industry median EV-to-EBIT is 18.06. Sabra Health Care REIT's value of 42.50 is 135.3% above this benchmark. While the company's 10-year median is 25.12 vs. the industry median of 18.06, Sabra Health Care REIT has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a REITs company?
The median EV-to-EBIT among REITs companies is 18.06, based on 653 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sabra Health Care REIT's current EV-to-EBIT of 42.50 is 135.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Sabra Health Care REIT and its competitors. For the REITs industry, the median EV-to-EBIT is 18.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sabra Health Care REIT's current EV-to-EBIT is 42.50, which is 69% above median its own 10-year median of 25.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sabra Health Care REIT stock overvalued right now?
Based on GuruFocus' analysis, Sabra Health Care REIT (SBRA) is currently considered Fairly Valued. The stock's GF Value™ is $20.33, compared to a current price of $21.06 — trading 3.6% above its estimated fair value. The current EV-to-EBIT is 42.50, which is 69% above median its 10-year median of 25.12 and 135.3% above the REITs industry median of 18.06. Sabra Health Care REIT's overall GF Score™ is 84/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Sabra Health Care REIT (SBRA), the current EV-to-EBIT is 42.50 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sabra Health Care REIT (SBRA) Overvalued in 2026?
Based on GuruFocus' analysis, Sabra Health Care REIT stock appears to be overvalued.
The current stock price of $21.06 is trading 3.6% above its estimated GF Value™ of $20.33.
GuruFocus considers Sabra Health Care REIT to be Fairly Valued.
Key valuation signals for SBRA:
EV-to-EBIT: 42.50 (69% above median its 10-year median of 25.12)
GF Value™: $20.33 vs. price of $21.06 (3.6% above fair value)
Industry Position: 135.3% above the REITs median (#571 of 653)
No single metric tells the full story. See the SBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
84GF Score
Get the complete analysis for SBRA
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBRA has been successfully added to your 
